Reply to the letter "Body mass index and clinical outcomes in trastuzumab-treated metastatic breast cancer patients: An alternative explanation for the lack of association"
Breast. 2018 Jun:39:151-152.
doi: 10.1016/j.breast.2018.03.003.
Epub 2018 Mar 17.
1 Department of Medical Oncology, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
2 Département d'hémato-oncologie, CISSS Montérégie centre/Hôpital Charles-Lemoyne, centre affilié de l'Université de Sherbrooke, Greenfield Park, QC, Canada.
3 Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: [email protected].
4 Department of Medical Oncology, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy; Department of Clinical Oncology, Unit of Medical Oncology and Cancer Prevention, CRO Aviano National Cancer Institute, Aviano, Italy; Department of Medicine, University of Udine, Italy.